Approved Treatments
Treatments in Development
Related Content
- New Directions in the Treatment of Non-Muscle Invasive Bladder Cancer
- Advancements and Insights in Non–Muscle-Invasive Bladder Cancer: Emerging PD-1/PD-L1 Inhibitors
- Emerging Treatments for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
- Emerging Treatments for Patients with NMIBC
- Key FDA decisions urologists can expect in the first half of 2025
